Only in Titles

           Search results for: Human Ovarian Cancer Antigen CA125 ELISA Kit   

paperclip

#24370956   2014/05/20 Save this To Up

Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.

To explore the potential and diagnostic performance of soluble mesothelin-related peptide (SMRP) as a tumor marker for epithelial ovarian cancer (EOC).

1722 related Products with: Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.

MarkerGene™ LysoLive™ CA125, Ovarian Cancer An CA125, Ovarian Cancer An CA125, Ovarian Cancer An RANK Ligand Soluble, Huma PSA test card, serum , Ca Rat ovarian cancer marker Triglyceride Assay Kit Li Cancer Markers CA 19 9 96 Ovarian cancer tissue arr Breast cancer tissue arra Breast cancer tissue arra

Related Pathways

paperclip

#24119905   2013/10/14 Save this To Up

[Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis].

To study the characteristics of HE4 expression in patients with epithelial ovarian cancer, and to evaluate whether the pre-treatment serum human epididymis protein 4 (HE4) level is an independent prognostic factor in the patients.

2625 related Products with: [Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis].

Frozen multiple human org Multiple ovarian cancer t Multiple ovarian cancer t Ovarian cancer tissue arr Ovarian cancer tissue arr Anti C Reactive Protein A Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Gro g Macrophage In

Related Pathways

paperclip

#23986888   2013/08/29 Save this To Up

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.

To evaluate procathepsin B, as well as endogenous inhibitors of cysteine proteases (cystatin B and cystatin C) in biological fluids as possible biomarkers of ovarian cancer. To observe levels of serum procathepsin B in different age groups.

2675 related Products with: Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.

Ovarian cancer tissue arr Bovine Androstenedione,AS Cat bladder cancer associ Cancer samples: Breast C Cancer samples: Ovarian Native Human Serum (Cysta Hidensity ovarian cancer CA125, Ovarian Cancer An CA125, Ovarian Cancer An CA125, Ovarian Cancer An Mouse anti-bovine type I Mouse anti-bovine type I

Related Pathways

paperclip

#21103788   2010/12/24 Save this To Up

The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer.

Our objective was to estimate the efficacy of the measurement of serum YKL-40 alone or with CA125 as biomarkers for the diagnosis of epithelial ovarian cancer (EOC) using the YKL-40 ELISA kit. An experimental group of 49 ovarian cancer patients included 42 patients with EOC (53 ± 15 years, range: 19-81 years) and 7 patients (48 ± 13 years, range: 29-36 years) with borderline epithelial ovarian tumor. A control group of 88 non-malignant cases included 42 patients (43 ± 10 years, range: 26-77 years) with benign gynecological disease and 46 healthy women (45 ± 14 years, range: 30-68 years) at a teaching hospital. Both YKL-40 (220.1 ± 94.1 vs 61.6 ± 48.4 and 50.1 ± 41.2 ng/mL) and CA125 (524.9 ± 972.5 vs 13.4 ± 7.6 and 28.5 ± 29.6 U/mL) levels were significantly higher (P < 0.05) in patients with ovarian cancer compared to the healthy and non-malignant groups. YKL-40 had 92.9% sensitivity and 94.4% specificity for the diagnosis of EOC. When YKL-40 and CA125 were tested in parallel, the sensitivity was increased to 98.2%, but the specificity was decreased to 81.3%. The correlations between serum YKL-40 and tumor stage, grade histology, performance status, patient age, and extension of debulking surgery were tested. With increasing stage and grade of EOC, preoperative serum YKL-40 levels were significantly increased (P = 0.029, P = 0.05, respectively). Serum YKL-40 alone or with serum CA125 levels are useful, although with some limitations, to diagnose ovarian cancer. Our study showed that YKL-40 may not be an independent prognostic factor for ovarian cancer. This prospective study may be a new trend in looking for biomarkers that optimize diagnosis of ovarian cancer.

1777 related Products with: The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer.

CA125, Ovarian Cancer An CA125, Ovarian Cancer An CA125, Ovarian Cancer An Rat ovarian cancer marker Human Ovarian Cancer Anti Ovarian cancer tissue arr Ovarian cancer metastasis Annexin V Biotin Reagent1 Annexin V Biotin Reagent1 Cell Meter™ Cell Viabil Cell Meter™ Annexin V B Cell Meter™ Annexin V B

Related Pathways

paperclip

#20825052   2010/09/09 Save this To Up

[Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients].

The aim of the study was to evaluate the usefulness of CA125 measurements in ovarian cancer diagnostics in pre- versus postmenopausal women.

1934 related Products with: [Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients].

Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian disease spectrum Ovary disease spectrum (o High density ovarian canc Multiple ovarian cancer t Multiple ovarian cancer t Ovarian cancer tissue arr Ovarian cancer tissue arr High density ovarian canc Ovarian cancer test tissu

Related Pathways

paperclip

#19134334   2009/01/12 Save this To Up

[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].

To evaluate the value of human epididymis secretory protein 4 (HE4) and CA(125) in the diagnosis of ovarian malignancy.

1216 related Products with: [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].

Recombinant Human PKC the Recombinant Human PKC the Recombinant Human PKC the Anti C Reactive Protein A Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Macrophage Inflamma Human Gro g Macrophage In Goat Anti-Human COL4A3BP Goat Anti-Human, Rat CHRN

Related Pathways

paperclip

#15099946   2004/04/21 Save this To Up

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.

Osteopontin (OPN) is overexpressed in tumors and serum of ovarian cancer patients and may serve as a biomarker. To evaluate the utility of serum osteopontin in monitoring disease status, we evaluated 234 serum samples from post-oophorectomy patients with ovarian cancer and 38 samples from healthy controls.

2496 related Products with: Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.

Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian disease spectrum Ovary disease spectrum (o High density ovarian canc Multiple ovarian cancer t Multiple ovarian cancer t Ovarian cancer tissue arr Ovarian cancer tissue arr High density ovarian canc Ovarian cancer test tissu

Related Pathways

paperclip

#2653700   1989/06/15 Save this To Up

Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.

There is increasing evidence to support the use of CA125 in the follow-up and management of patients with ovarian cancer and several commercial kits are now available for its measurement. This study investigated and compared the performance of three of them: an enzyme immunoassay (EIA) and an immunoradiometric assay (IRMA) from Abbott Diagnostics, and an IRMA from CIS, U.K. One hundred and thirty-two serum samples from 42 patients with advanced epithelial ovarian cancer were thawed once and assayed for CA125 using each kit. Both IRMAs performed better than the EIA in terms of CV, sensitivity, specificity, and accuracy. The results confirm the usefulness of CA125 as a marker for ovarian cancer. However, discrepancies between results using different kits suggest the need for improved standardization.

2338 related Products with: Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.

Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian cancer tissue arr Ovarian disease spectrum Ovary disease spectrum (o High density ovarian canc Multiple ovarian cancer t Multiple ovarian cancer t Ovarian cancer tissue arr Ovarian cancer tissue arr High density ovarian canc Ovarian cancer test tissu

Related Pathways